These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13743435)

  • 21. [Immunochemical studies on coagulant, fibrinolytic factors and proteinase inhibitors in fraction (I) separated with lysine-sepharose affinity chromatography (author's transl)].
    Miyatani K
    Rinsho Byori; 1980 Oct; 28(10):1047-50. PubMed ID: 7253274
    [No Abstract]   [Full Text] [Related]  

  • 22. Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis.
    Aguilar I; Guerrero B; Maria Salazar A; Girón ME; Pérez JC; Sánchez EE; Rodríguez-Acosta A
    Toxicon; 2007 Aug; 50(2):214-24. PubMed ID: 17482229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmacodynamic effect of urea on blood circulation and respiration after prolonged intravenous administration].
    CUPARENCU B; GROSU L; ZAGREANU I; DOROFTEIU M; COJOCARU A
    Acta Biol Med Ger; 1961; 6():202-12. PubMed ID: 13718875
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulation savers: thrombolytic therapy.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2013; 22(6):393-7. PubMed ID: 24600937
    [No Abstract]   [Full Text] [Related]  

  • 25. Action of Trimeresurus flavoviridis venom on the microcirculatory system of rat; dynamic aspects as revealed by cinephotomicrographic recording.
    Osaka A; Oashi M; Tsuchiya M; Kamisaka Y; Fujishiro Y
    Jpn J Med Sci Biol; 1971 Feb; 24(1):34-9. PubMed ID: 5314270
    [No Abstract]   [Full Text] [Related]  

  • 26. [On blood coagulation activity of several reptile toxins].
    KORNALIK F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 240():72-8. PubMed ID: 13753185
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of the inflammatory and coagulant action of Bothrops atrox venom by the plant species Marsypianthes chamaedrys.
    Magalhães A; Santos GB; Verdam MC; Fraporti L; Malheiro A; Lima ES; Dos-Santos MC
    J Ethnopharmacol; 2011 Mar; 134(1):82-8. PubMed ID: 21130858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of landfill leachate by using lateritic soil as a natural coagulant.
    Syafalni ; Lim HK; Ismail N; Abustan I; Murshed MF; Ahmad A
    J Environ Manage; 2012 Dec; 112():353-9. PubMed ID: 22964042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological study of some properties of LG-11457. Action on ventricular extrasystoles, on spasm of smooth muscles and on the peripheral circulation].
    DELL'OMODARME G; GIANNONI G
    Minerva Med; 1960 Sep; 51(70 Suppl):2839-47. PubMed ID: 13721592
    [No Abstract]   [Full Text] [Related]  

  • 30. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J; O'Leary MA; Isbister GK
    Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood circulation studies on the effect of niamide].
    KLEIN K
    Med Klin; 1961 Apr; 56():760-3. PubMed ID: 15445372
    [No Abstract]   [Full Text] [Related]  

  • 32. Venom variation in hemostasis of the southern Pacific rattlesnake (Crotalus oreganus helleri): isolation of hellerase.
    Salazar AM; Guerrero B; Cantu B; Cantu E; Rodríguez-Acosta A; Pérez JC; Galán JA; Tao A; Sánchez EE
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):307-16. PubMed ID: 18804187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the effectiveness of conventional and alternative coagulants through effective characterization schemes.
    Sinha S; Yoon Y; Amy G; Yoon J
    Chemosphere; 2004 Dec; 57(9):1115-22. PubMed ID: 15504470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin-like and factor X-activator components of Bothrops snake venoms.
    Nahas L; Kamiguti AS; Barros MA
    Thromb Haemost; 1979 Apr; 41(2):314-28. PubMed ID: 473115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical-experimental studies on the effect of unsaturated fatty acids on the blood circulation].
    KLEIN K
    Z Kreislaufforsch; 1960 Nov; 49():1022-30. PubMed ID: 13756665
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution to the study of the preservation of blood in relation to anti-coagulant solutions and contact surfaces].
    MORATI-SCHMITT M; DENHAUT G; REVOL L
    Transfusion (Paris); 1961; 4():183-99. PubMed ID: 14475809
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the pharmacology of vipratox].
    RAIAVEE OL
    Farmakol Toksikol; 1961; 24():713-9. PubMed ID: 14489915
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-coagulant medication].
    SADA QUIROGA E
    Torreon Med; 1950; 5(1):1-10. PubMed ID: 15404446
    [No Abstract]   [Full Text] [Related]  

  • 39. The use and control of anti-coagulant drugs in medicine.
    WELLS GH
    Hahnemannian; 1949; 84(4):230-5. PubMed ID: 15408218
    [No Abstract]   [Full Text] [Related]  

  • 40. Animal toxins and their advantages in biotechnology and pharmacology.
    Da Silva SL; Rowan EG; Albericio F; Stábeli RG; Calderon LA; Soares AM
    Biomed Res Int; 2014; 2014():951561. PubMed ID: 24977166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.